Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Award Notice opportunity from Department Of Defense was posted on August 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

LABETALOL HYDROCHLORIDE INJECTION

Awarded
SPE2DP26F9269Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

Defense Logistics Agency award SPE2DP26F9269 is a delivery order issued on August 28, 2026, to DMS Pharmaceutical Group Inc under the base administrative contract SPE2DX25D9900. This specific order is for the procurement of Labetalol Hydrochloride Injection, identified by NSN 6505012447982, with a total contract price of 8.46 dollars for three vials at a unit price of 2.82 dollars. The delivery for these medical supplies is scheduled for September 14, 2026. The overarching base contract, SPE2DX25D9900, was issued on April 2, 2025, by the DLA Troop Support Medical Supply Chain for commercial items under NAICS code 325412, with a total award value of 19,999,999.00 dollars. This base agreement replaces the previous contract SPE2DX25D9383 and provides the administrative framework for individual delivery orders such as the one for Labetalol Hydrochloride Injection.

General Info

DLA awarded DMS Pharmaceutical Group $8.46 for Labetalol Hydrochloride Injection by September 2026.

Contract Value

$8.46

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

2
PDF, High priority: read this first3 pages · task-order-award
High
PDF, High priority: read this first4 pages · award
High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F9269 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $8.46 Award Date: 08-28-2026 Delivery order under: SPE2DX25D9900 Line items: - LABETALOL HYDROCHLORIDE INJECTION (NSN/Part 6505012447982, PR 7018111722)

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS